In the Headlines
December 4, 2017
CVS-Aetna Deal May Hinge on Antitrust Approach Under Trump
Bloomberg
The recent deal with CVS Health Corp. and Aetna Inc. has attracted scrutiny for antitrust issues. Although the deal has implied to improve the accessibility and efficiency of healthcare for consumers, past settlements with behavioral restrictions have received tough criticism.
"That doesn’t mean there’s heightened hostility toward vertical deals at the Justice Department, but CVS might prefer the Aetna deal to go to the FTC given Delrahim’s criticism of behavioral fixes," said Attorney David Kully.
READ: CVS-Aetna Deal May Hinge on Antitrust Approach Under Trump